Approval · Notice of Compliance 8995 · 2007
ZELDOX: Notice of Compliance 8995
Issued August 27, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8995
- Date
- August 27, 2007
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antipsychotic agent
Products in this notice
Medicinal ingredients
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 20 MG per CAP
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 40 MG per CAP
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 60 MG per CAP
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 80 MG per CAP